Clinical trial
A Pilot Investigation of Recombinant Human Bone Morphogenetic Protein- 2/Biphasic Calcium Phosphate in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion
NCT01495234 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Investigation of Recombinant Human Bone Morphogenetic Protein- 2/Biphasic Calcium Phosphate in Patients With Spinal Degeneration With Instability Requiring Surgical Fusion
- Lead sponsor
- Medtronic Spinal and Biologics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 1996
- Completion date
- June 30, 2001
- Enrollment
- 15 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative disc disease